Thrivent Financial for Lutherans Has $73.49 Million Holdings in Encompass Health Co. (NYSE:EHC)

Thrivent Financial for Lutherans increased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 26.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 760,496 shares of the company's stock after acquiring an additional 156,938 shares during the quarter. Thrivent Financial for Lutherans owned 0.75% of Encompass Health worth $73,494,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in EHC. UMB Bank n.a. raised its holdings in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after acquiring an additional 140 shares during the period. Oakworth Capital Inc. acquired a new stake in shares of Encompass Health during the second quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock valued at $46,000 after acquiring an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Encompass Health during the second quarter valued at approximately $58,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Royal Bank of Canada boosted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research report on Wednesday, October 30th. Barclays boosted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. UBS Group boosted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Stephens reaffirmed an "overweight" rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Finally, Truist Financial reaffirmed a "buy" rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $107.11.

Encompass Health Stock Performance

Shares of NYSE EHC traded up $0.37 during trading hours on Monday, hitting $99.22. 679,535 shares of the stock were exchanged, compared to its average volume of 641,751. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The company's 50 day moving average is $96.54 and its 200 day moving average is $90.46. The firm has a market capitalization of $10.00 billion, a P/E ratio of 23.97, a P/E/G ratio of 1.31 and a beta of 0.88. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health's quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.86 EPS. On average, research analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is currently 16.43%.

Encompass Health declared that its board has approved a stock buyback plan on Wednesday, July 24th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 5.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board of directors believes its shares are undervalued.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.